Stay updated on TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial

Sign up to get notified when there's something new on the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.2 to v3.8.0; the study record remains unavailable on the 403 error page.
    Difference
    0.2%
    Check dated 2026-11-03T15:51:49.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner about NIH’s terminology transition appears above the ClinicalTrials.gov page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T18:49:01.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:48:12.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, preventing access to the trial details and related documents. The page shows a 403 header with a generic footer, including a Home link.
    Difference
    19%
    Check dated 2026-09-22T22:56:44.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study record updates sponsor and collaborator information by adding Healx AI and noting Takeda’s divestment to Mistrau Bio, while older sponsor entries from 2021 were removed.
    Difference
    0.3%
    Check dated 2026-09-15T21:39:04.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added Tel Litwinsky, Ramat Gan, Israel, 52621 as a study location and added Ovid Therapeutics Inc. as a collaborator. Removed Qiryat Krinitzi, Ramat Gan, Israel, 52621 as a study location and Healx AI as a collaborator.
    Difference
    0.2%
    Check dated 2026-09-08T17:43:59.000Z thumbnail image

Stay in the know with updates to TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page.